145 related articles for article (PubMed ID: 27098652)
1. The heparan sulphate deficient Hspg2 exon 3 null mouse displays reduced deposition of TGF-β1 in skin compared to C57BL/6 wild type mice.
Shu C; Smith SM; Melrose J
J Mol Histol; 2016 Jun; 47(3):365-74. PubMed ID: 27098652
[TBL] [Abstract][Full Text] [Related]
2. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
3. Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.
Shu CC; Smith MM; Appleyard RC; Little CB; Melrose J
PeerJ; 2018; 6():e5120. PubMed ID: 30042881
[TBL] [Abstract][Full Text] [Related]
4. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunolocalisation of fibrillin-1 and perlecan in the human foetal, and HS-deficient hspg2 exon 3 null mutant mouse intervertebral disc.
Hayes AJ; Smith SM; Melrose J
Histochem Cell Biol; 2013 Jan; 139(1):1-11. PubMed ID: 23104139
[TBL] [Abstract][Full Text] [Related]
6. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
7. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
[TBL] [Abstract][Full Text] [Related]
8. Type XI collagen-perlecan-HS interactions stabilise the pericellular matrix of annulus fibrosus cells and chondrocytes providing matrix stabilisation and homeostasis.
Smith SM; Melrose J
J Mol Histol; 2019 Jun; 50(3):285-294. PubMed ID: 30993430
[TBL] [Abstract][Full Text] [Related]
9. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
10. Confocal microscopy demonstrates association of LTBP-2 in fibrillin-1 microfibrils and colocalisation with perlecan in the disc cell pericellular matrix.
Hayes AJ; Gibson MA; Shu C; Melrose J
Tissue Cell; 2014 Jun; 46(3):185-97. PubMed ID: 24867584
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.
Rossi M; Morita H; Sormunen R; Airenne S; Kreivi M; Wang L; Fukai N; Olsen BR; Tryggvason K; Soininen R
EMBO J; 2003 Jan; 22(2):236-45. PubMed ID: 12514129
[TBL] [Abstract][Full Text] [Related]
12. Perlecan-deficient mutation impairs corneal epithelial structure.
Inomata T; Ebihara N; Funaki T; Matsuda A; Watanabe Y; Ning L; Xu Z; Murakami A; Arikawa-Hirasawa E
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1277-84. PubMed ID: 22266517
[TBL] [Abstract][Full Text] [Related]
13. Perlecan/Hspg2 deficiency alters the pericellular space of the lacunocanalicular system surrounding osteocytic processes in cortical bone.
Thompson WR; Modla S; Grindel BJ; Czymmek KJ; Kirn-Safran CB; Wang L; Duncan RL; Farach-Carson MC
J Bone Miner Res; 2011 Mar; 26(3):618-29. PubMed ID: 20814969
[TBL] [Abstract][Full Text] [Related]
14. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
15. Dyssegmental dysplasia, Silverman-Handmaker type, is caused by functional null mutations of the perlecan gene.
Arikawa-Hirasawa E; Wilcox WR; Le AH; Silverman N; Govindraj P; Hassell JR; Yamada Y
Nat Genet; 2001 Apr; 27(4):431-4. PubMed ID: 11279527
[TBL] [Abstract][Full Text] [Related]
16. Perlecan is essential for cartilage and cephalic development.
Arikawa-Hirasawa E; Watanabe H; Takami H; Hassell JR; Yamada Y
Nat Genet; 1999 Nov; 23(3):354-8. PubMed ID: 10545953
[TBL] [Abstract][Full Text] [Related]
17. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.
Xu Z; Ichikawa N; Kosaki K; Yamada Y; Sasaki T; Sakai LY; Kurosawa H; Hattori N; Arikawa-Hirasawa E
Matrix Biol; 2010 Jul; 29(6):461-70. PubMed ID: 20541011
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
[TBL] [Abstract][Full Text] [Related]
19. Synovial perlecan is required for osteophyte formation in knee osteoarthritis.
Kaneko H; Ishijima M; Futami I; Tomikawa-Ichikawa N; Kosaki K; Sadatsuki R; Yamada Y; Kurosawa H; Kaneko K; Arikawa-Hirasawa E
Matrix Biol; 2013 Apr; 32(3-4):178-87. PubMed ID: 23339896
[TBL] [Abstract][Full Text] [Related]
20. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
